why choose us

First received: February 27, 2023

Clinical Trial: Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor

Study Status: Completed

Recruit Status: RECRUITING

Condition: Intradialytic Hypotension

Study Type: INTERVENTIONAL


Official Title: Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor A Randomized, Double-blind, Placebo-controlled, Cross Over Explorative Study

Brief Summary: Currently, there is no medication available to adequately treat patients undergoing hemodialysis who are suffering from intradialytic hypotension (IDH).Medical interventions such as Trendelenburg positioning, saline bolus administration, reduction of ultrafiltration rate, interruption of the hemodialysis, and other medical treatments are the methods of choice to treat the hypotensive condition of these patients and thus to maintain the systolic blood pressure.Patients suffering from IDH have a higher reported…

Read more